American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$276M |
| 2 |
NVIDIA
NVDA
|
+$243M |
| 3 |
Meta Platforms (Facebook)
META
|
+$206M |
| 4 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$165M |
| 5 |
Colgate-Palmolive
CL
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Microsoft
MSFT
|
+$544M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$322M |
| 4 |
L3Harris
LHX
|
+$254M |
| 5 |
Idexx Laboratories
IDXX
|
+$227M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Reinsurance Group of America
RGA
$16.2B
| $206M | 0.16% |
1,552,726
-106,211
| -6% | -$15M |
|
152
Champion Homes
SKY
$5.13B
| $203M | 0.16% |
2,697,094
-43,071
| -2% | -$2.78M |
|
|
SCHW
153
Charles Schwab
SCHW
$190B
| $201M | 0.16% |
3,835,336
+1,246,652
| +48% | +$91.3M |
|
|
BDXB
154
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $199M | 0.16% |
3,997,703
+38,657
| +1% | +$1.91M |
|
155
Amcor
AMCR
$21.3B
| $199M | 0.16% |
3,488,820
+768,050
| +28% | +$44M |
|
156
Manhattan Associates
MANH
$11.4B
| $198M | 0.16% |
1,280,782
+31,104
| +2% | +$4.28M |
|
157
Cognex
CGNX
$10.2B
| $196M | 0.15% |
3,999,399
+197,016
| +5% | +$9.97M |
|
158
Healthpeak Properties
DOC
$14.4B
| $195M | 0.15% |
8,873,653
-2,046,876
| -19% | -$50.8M |
|
159
Cintas
CTAS
$81.4B
| $191M | 0.15% |
1,654,956
-1,414,808
| -46% | -$156M |
|
160
Union Pacific
UNP
$176B
| $189M | 0.15% |
940,967
+26,852
| +3% | +$5.44M |
|
161
TotalEnergies
TTE
$192B
| $189M | 0.15% |
3,193,093
+82,020
| +3% | +$5.04M |
|
162
Gilead Sciences
GILD
$169B
| $188M | 0.15% |
2,271,017
+1,106,924
| +95% | +$91.7M |
|
163
TSMC
TSM
$2.24T
| $188M | 0.15% |
2,017,562
+187,522
| +10% | +$16.8M |
|
164
Becton Dickinson
BDX
$49.9B
| $187M | 0.15% |
753,726
-45,271
| -6% | -$11.1M |
|
165
Unilever
UL
$134B
| $186M | 0.15% |
3,183,450
-44,754
| -1% | -$2.54M |
|
166
Waters Corp
WAT
$40.3B
| $184M | 0.15% |
594,506
+53,204
| +10% | +$17.2M |
|
167
Cencora
COR
$59.6B
| $184M | 0.14% |
1,148,135
+75,469
| +7% | +$12M |
|
168
Regency Centers
REG
$14B
| $183M | 0.14% |
2,992,984
+54,720
| +2% | +$3.44M |
|
|
HES
169
DELISTED
Hess
HES
| $183M | 0.14% |
1,383,889
+35,846
| +3% | +$4.99M |
|
170
Palo Alto Networks
PANW
$321B
| $181M | 0.14% |
1,815,382
+40,778
| +2% | +$3.46M |
|
171
Ameriprise Financial
AMP
$50B
| $179M | 0.14% |
585,976
-43,781
| -7% | -$14.3M |
|
172
Labcorp
LH
$26.3B
| $178M | 0.14% |
902,483
+58,300
| +7% | +$12M |
|
173
FMC
FMC
$1.26B
| $178M | 0.14% |
1,464,466
-251,967
| -15% | -$31.7M |
|
174
Coherent
COHR
$68.1B
| $176M | 0.14% |
4,624,897
-5,270
| -0.1% | -$214K |
|
175
Aflac
AFL
$60.9B
| $176M | 0.14% |
2,722,423
-97,062
| -3% | -$6.64M |
|
Similar funds
American Century Companies's Q1 2023 Portfolio in Review
As of Q1 2023, American Century Companies held 2,730 positions worth $127B, up 3.7% from $122B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
American Century Companies's Q1 2023 filing shows 153 new, 1,696 increased, 700 reduced and 63 closed positions. Its largest new stake was Atlassian: 260,346 shares worth $44.6M. The largest sale was Amazon, an estimated $615M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q1 2023 buy was Atlassian: 260,346 shares worth $44.6M.
- American Century Companies added most to Humana in Q1 2023, an estimated $276M increase.
- American Century Companies's biggest Q1 2023 reduction was Amazon, cutting an estimated $615M.
- American Century Companies fully exited SVB Financial Group in Q1 2023, selling an estimated $73M.
- American Century Companies's ten largest holdings make up 20% of its $127B portfolio in Q1 2023.
- American Century Companies opened 153 new positions and closed 63 in Q1 2023.
- American Century Companies's portfolio value rose 3.7% quarter-over-quarter to $127B.
Based on American Century Companies's 13F filing for Q1 2023, filed 11 May 2023.